AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Patients With Advanced Solid Malignancies
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to assess the safety, tolerability and pharmacokinetics
of a capsule of AZD6244 in patients with advanced solid malignancies